@FierceBiotech: FierceBiotech's first special report of 2014: An ominous trend resurfaces as new drug approvals plunge in 2013. Report | Follow @FierceBiotech
@JohnCFierce: GE beefs up life sciences division with $1.06B Thermo Fisher deal. Story | Follow @JohnCFierce
@DamianFierce: "Moon Shots" = excellent naming. MD Anderson teams up with Pfizer to advance cancer immunotherapy. Release | Follow @DamianFierce
@EmilyMFierce: 6 U.S. institutions receive $540M in cancer research funds. Item | Follow @EmilyMFierce
> San Diego-based Halozyme Therapeutics ($HALO) has obtained a $20 million loan from Oxford Finance and Silicon Valley Bank. Release
> Israel's BrainStorm Cell Therapeutics is touting the response of a single elderly patient with Lou Gehrig's disease and myasthenia gravis to a therapy using its adult stem cells. Story
Medical Device News
@FierceMedDev: TrovaGene recruits US Oncology Research for a pancreatic cancer Dx trial. News | Follow @FierceMedDev
@MichaelGFierce: Gene delivery method 'hijacks' tumor blood vessels. More | Follow @MichaelGFierce
> Medtronic gives it another go with atrial fibrillation device. News
> Topera snags FDA OK for latest heart-mapping tech. Story
> Quest beefs up its Indian presence as stateside sales sag. Piece
> Thermo nears Life Tech merger with $1.1B sale to GE. Article
Pharma News
@FiercePharma: Rebel Teva shareholder throws his support to presumptive CEO Vigodman. Story | Follow @FiercePharma
@EricPFierce: There were fewer NDA's approved by the FDA in 2013, but there were some significant ones. Report | Follow @EricPFierce
@CarlyHFierce: Bayer's hot-selling Eylea runs into a roadblock in its home market. More | Follow @CarlyHFierce
> Rebel Teva shareholder throws his support to presumptive CEO Vigodman. News
> Celgene, Boston Children's play tug-of-war over Revlimid royalties. Article
> Is the audience listening? FDA wants to spy on social media to find out. More
CRO News
> Cyprotex bags a U.S. CRO for up to $5.1M. Report
> DaVita ups its CRO weight with latest partnership. News
> Sanofi stops short of baring it all with clinical trial transparency pledge. More
> Can Parexel regain some confidence after a major slip? Article
> India further tightens clinical trial rules as demand plummets. Story
> Report: Big or small, CROs need good relationships to thrive. Item
Biotech IT News
> Google VC commits to $15M round to advance DNAnexus' data hub ambitions. Report
> NIH puts improved data handling at top of BRAIN Initiative wish list. Story
> FDA plans raft of IT guidance documents to further GDUFA goals. News
> Days after Big Pharma trumpets data sharing plans, U.K. politicians push for more transparency. Article
> Spun out of George Church's lab, Curoverse gets $1.5M for open-source bio Big Data. More
> IMS Health files for IPO after making string of tech takeovers. Item